switched from 5mg to 2.5mg and the constipation got better, not worse
I have had 24 orders now and I keep a table, so here is the honest summary rather than a vibe.
Material has been consistent. Communication has not. Shipping has varied by about 10 days on nominally the same lane, which matters more in summer than in February.
The independent number came back 98.4% against a claimed 98.6%, which I read as agreement rather than a discrepancy — inter-lab variance on this assay is a point or two either way and treating one lab as ground truth is how people end up in pointless arguments with vendors.
Batch number is in the comments. Ask if you want the method.
best — the order this archive was captured in
This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.
phase 2 numbers are not maintenance numbers, cite the trial
This is correct. Triple agonism is genuinely different.
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
Strongly agree. Heart rate escalation needs the actual data, not impressions.
Did you actually measure heart rate or is that a feeling?
TRIUMPH data is phase 2, not phase 3, smaller n and shorter
the glucagon component changes the side effect profile, not just the efficacy
Strongly agree. Heart rate escalation needs the actual data, not impressions.
Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.
This is correct. Triple agonism is genuinely different.
the weight curves are unusually steep, which makes predicting individual response harder
Did you actually measure heart rate or is that a feeling?
phase 2 numbers are not maintenance numbers, cite the trial
the weight curves are unusually steep, which makes predicting individual response harder
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
retatrutide is not approved anywhere for human use, posts must not read as instructions
retatrutide is not approved anywhere for human use, posts must not read as instructions
Adding to this: TRIUMPH is doing more work than the comment implies.
research use only, handling and analysis, not protocols
Strongly agree. Heart rate escalation needs the actual data, not impressions.
the weight curves are unusually steep, which makes predicting individual response harder Counter-anecdote: opposite result, same dose.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
the glucagon component changes the side effect profile, not just the efficacy
the dosing is steep, the sulphur burps reports are real, and nobody knows the human safety yet
The confident tone is doing a lot of work that the evidence is not.
triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual
- 1the weight curves are unusually steep, which makes predicting individual…11 comments in this branch · started by u/employer_carveout
- 2This is correct. Triple agonism is genuinely different.7 comments in this branch · started by u/hugo_pires